Editorial p871 Weighing the benefits of screening for early-onset colorectal cancer The Lancet Gastroenterology & Hepatology + + + +...

Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00129-3/abstract?utm_campaign=update-langas&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_langas&_hsenc=p2ANqtz-9zjPK02f5rpnCmZlYZ37oKG5z45ajoh7v45S7pjRhx41FI0eUC1n6vPkaLggrud5RuMWkngI1GibVDV1qZ32abxLWSRg&_hsmi=380829353&utm_content=380782076&utm_source=hs_email Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00128-1/abstract?utm_campaign=update-langas&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_langas&_hsenc=p2ANqtz-_kaQ0znacVgSgalgyBGK2LIE9KFlENoHeS3orePvBWh7qjU6tCwrXQAxV9Zdy1br9FNgdungPm_kiKf35YsKyG_uUWoQ&_hsmi=380829353&utm_content=380782076&utm_source=hs_email Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational study https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00133-5/abstract?utm_campaign=update-langas&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_langas&_hsenc=p2ANqtz-9f-4K2QxzeVXDsMPCJadwZinxz4RGNfk1Tf_JuspjiWlS7M55rF8OYRQWBqOphTUlTh3hjyuwdd2YfkNwTxYS6EO3O1A&_hsmi=380829353&utm_content=380782076&utm_source=hs_email Editorial p871 Weighing the benefits of screening for early-onset colorectal cancer The Lancet Gastroenterology & Hepatology https://www.thelancet.com/journals/langas/issue/vol10no10/PIIS2468-1253(25)X0009-1